Partial Thromboplastin Time (PTT)
Customize your policy alerts
Sign up for Providence Health Plan Policy 326 alerts
Get alerted when Policy 326 changes without checking for updates manually.
Monitor payer policy activity
This Medicare medical policy governs coverage and billing of the Partial Thromboplastin Time (PTT) laboratory test for Medicare beneficiaries. Coverage follows Medicare NCD 190.16 and requires applicable Medicare medical-necessity criteria and diagnosis coding.
The ICD-10 diagnosis configuration was updated for the October 2026 CMS update under CR 14536.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.